This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Peralta, A. O. Articles by Venditti, F. J. Search for Related Content PubMed PubMed Citation Articles by Peralta, A. O. Articles by Venditti, F. J.

EXPERIMENTAL STUDY

The class III antiarrhythmic effect of sotalol exerts a reverse use-dependent positive inotropic effect in the intact canine heart

^a Section of Cardiovascular Medicine and Laser Research Laboratory, Lahey Clinic Medical Center, Burlington, Massachusetts, USA
^* University College, London, United Kingdom

Manuscript received December 9, 1998; revised manuscript received March 23, 2000, accepted May 24, 2000.

Reprint requests and correspondence: Dr. Roy M. John, Section of Cardiovascular Medicine, Lahey Clinic Medical Center, 41 Mall Road, Burlington, Massachusetts 01805
Roy.M.John{at}Lahey.org

OBJECTIVES

We sought to study the rate related effects of sotalol on myocardial contractility and to test the hypothesis that the class III antiarrhythmic effect of sotalol has a reverse use-dependent positive inotropic effect in the intact heart.

BACKGROUND

Antiarrhythmic drugs exert significant negative inotropic effects. Sotalol, a beta-adrenergic blocking agent with class III antiarrhythmic properties, may augment contractility by virtue of its ability to prolong the action potential duration (APD).

METHODS

In 10 anesthetized dogs, measurements of left ventricle (LV) peak (+)dP/dt and simultaneous endocardial action potentials were made during baseline conditions and after sequential administration of esmolol and sotalol. In addition, electrical and mechanical restitution curves were constructed at a basic pacing cycle length of 600 ms by introducing a test pulse of altered cycle length ranging from 200 ms to 2,000 ms.

RESULTS

In the steady state pacing experiments, sotalol prolonged the APD in a reverse use-dependent manner; such an effect was not seen with esmolol. At cycle lengths exceeding 400 ms, LV (+)dP/dt was significantly higher with sotalol than it was with esmolol. There was a direct relation between APD and LV (+)dP/dt with sotalol (r = 0.46, p < 0.001), but there was no significant relation between APD and LV (+)dP/dt with esmolol (r = 0.27, p = NS). Results in the single beat (restitution) studies were qualitatively similar to the steady state results; APD (at cycle length >400 ms) and LV (+)dP/dt (at cycle length >600 ms) were significantly higher with sotalol than they were with esmolol.

CONCLUSIONS

The reverse use-dependent prolongation of APD by sotalol is associated with a positive inotropic effect.

Abbreviations and Acronyms   APD = action potential duration   AV = atrioventricular   LV = left ventricle or ventricular   MAP = monophasic action potential   dP/dt = time derivative of pressure

This article has been cited by other articles:

				H. Endo, M. Miura, M. Hirose, J. Takahashi, M. Nakano, Y. Wakayama, Y. Sugai, Y. Kagaya, J. Watanabe, K. Shirato, et al. Reduced Inotropic Effect of Nifekalant in Failing Hearts in Rats J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1102 - 1107. [Abstract] [Full Text] [PDF]